Migraine. Migraine without aura [common migraine]
Conditions
Interventions
Intervention 1: Intervention group:The intervention group consists of 40 people and they are given propranolol and almond tablets. Propranol tablets 10 mg twice a day and almond tablets 500 mg twice a
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Suffering from a migraine headache with the approval of a neurologist Signing an informed consent form Age 15 to 45 years
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Addiction to cigarettes and drugs Simultaneous use of other drugs such as antiepileptics, benzodiazepines, barbiturates Simultaneously suffering from chronic liver, kidney, heart and other neurological diseases except migraine Unwillingness to continue cooperation Failure to follow the correct way of taking the prescribed medicine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of headache. Timepoint: At the beginning of the study, 2, 4 after starting and 2 weeks after finishing the drug. Method of measurement: Visual Analogue Scale, The short Form Health Survey, Headache Impact Test-6. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: At the beginning of the study, 2-4 weeks after starting and 2 weeks after finishing the drug. Method of measurement: Visual Analogue Scale, The short Form Health Survey, Headache Impact Test-6.;Number of attacks. Timepoint: Number of attacks per week. Method of measurement: Questione.;Duration of headache. Timepoint: Number of attacks per week. Method of measurement: Question. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoud Moghaderi
Kerman University of Medical Sciences
Outcome results
None listed